ID

35256

Beskrivning

A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02068222

Länk

https://clinicaltrials.gov/show/NCT02068222

Nyckelord

  1. 2019-02-25 2019-02-25 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

25 februari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Chronic Hepatitis C NCT02068222

Eligibility Chronic Hepatitis C NCT02068222

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female (of non-child bearing potential) between 18 and 70 years of age with body mass index ≥18 to <38 kg/m2.
Beskrivning

Gender | Female infertility | Age | Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0021361
UMLS CUI [3]
C0001779
UMLS CUI [4]
C1305855
chronic hcv genotype 3 infection prior to study enrollment and has never received antiviral treatment for hcv.
Beskrivning

Chronic Hepatitis C Genotype | Antiviral Therapy Absent Hepatitis C virus

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C0017431
UMLS CUI [2,1]
C0280274
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0220847
subject has plasma hcv rna level > 10,000 iu/ml at screening.
Beskrivning

Plasma Hepatitis C virus RNA assay

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C1272251
sexually active males must be sterile, have male partners only, or agree to use two effective forms of birth control for 7 months after stopping study drug.
Beskrivning

Gender Sexually active Infertility | Partner Male | Gender Sexually active Contraceptive methods Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0241028
UMLS CUI [1,3]
C0021359
UMLS CUI [2,1]
C0682323
UMLS CUI [2,2]
C0086582
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0241028
UMLS CUI [3,3]
C0700589
UMLS CUI [3,4]
C1265611
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of severe, life-threatening or other significant sensitivity to any drug.
Beskrivning

Drug Allergy Severe | Drug Allergy Life Threatening | Drug Allergy Significant

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C2826244
UMLS CUI [3,1]
C0013182
UMLS CUI [3,2]
C0750502
positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
Beskrivning

Hepatitis B surface antigen positive | HIV antibody positive

Datatyp

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0920548
prior therapy for the treatment of hcv.
Beskrivning

Prior Therapy Hepatitis C virus

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0220847
any current or past clinical evidence of cirrhosis.
Beskrivning

Liver Cirrhosis | Liver Cirrhosis In the past

Datatyp

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C1444637
any cause of liver disease other than chronic hcv-infection.
Beskrivning

Liver disease Cause Any | Exception Chronic Hepatitis C

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C1552551
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0524910
hcv genotype co-infection with any other hcv genotype.
Beskrivning

HCV coinfection Genotype | Hepatitis C virus genotype Other

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1698259
UMLS CUI [1,2]
C0017431
UMLS CUI [2,1]
C1148363
UMLS CUI [2,2]
C0205394
use of contraindicated medications within 2 weeks or 10 half-lives of dosing.
Beskrivning

Pharmaceutical Preparations Contraindicated

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444657

Similar models

Eligibility Chronic Hepatitis C NCT02068222

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Female infertility | Age | Body mass index
Item
male or female (of non-child bearing potential) between 18 and 70 years of age with body mass index ≥18 to <38 kg/m2.
boolean
C0079399 (UMLS CUI [1])
C0021361 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C1305855 (UMLS CUI [4])
Chronic Hepatitis C Genotype | Antiviral Therapy Absent Hepatitis C virus
Item
chronic hcv genotype 3 infection prior to study enrollment and has never received antiviral treatment for hcv.
boolean
C0524910 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
C0280274 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
Plasma Hepatitis C virus RNA assay
Item
subject has plasma hcv rna level > 10,000 iu/ml at screening.
boolean
C0032105 (UMLS CUI [1,1])
C1272251 (UMLS CUI [1,2])
Gender Sexually active Infertility | Partner Male | Gender Sexually active Contraceptive methods Quantity
Item
sexually active males must be sterile, have male partners only, or agree to use two effective forms of birth control for 7 months after stopping study drug.
boolean
C0079399 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0021359 (UMLS CUI [1,3])
C0682323 (UMLS CUI [2,1])
C0086582 (UMLS CUI [2,2])
C0079399 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
Item Group
C0680251 (UMLS CUI)
Drug Allergy Severe | Drug Allergy Life Threatening | Drug Allergy Significant
Item
history of severe, life-threatening or other significant sensitivity to any drug.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0013182 (UMLS CUI [2,1])
C2826244 (UMLS CUI [2,2])
C0013182 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
Hepatitis B surface antigen positive | HIV antibody positive
Item
positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
boolean
C0149709 (UMLS CUI [1])
C0920548 (UMLS CUI [2])
Prior Therapy Hepatitis C virus
Item
prior therapy for the treatment of hcv.
boolean
C1514463 (UMLS CUI [1,1])
C0220847 (UMLS CUI [1,2])
Liver Cirrhosis | Liver Cirrhosis In the past
Item
any current or past clinical evidence of cirrhosis.
boolean
C0023890 (UMLS CUI [1])
C0023890 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
Liver disease Cause Any | Exception Chronic Hepatitis C
Item
any cause of liver disease other than chronic hcv-infection.
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
HCV coinfection Genotype | Hepatitis C virus genotype Other
Item
hcv genotype co-infection with any other hcv genotype.
boolean
C1698259 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
C1148363 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Pharmaceutical Preparations Contraindicated
Item
use of contraindicated medications within 2 weeks or 10 half-lives of dosing.
boolean
C0013227 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial